Fitzgerald Kevin Joseph

EDGAR CIK 0001886431

Alnylam Pharmaceuticals, Inc. - ALNY

Officer
CSO & EVP, Head of Research
Direct Buys
0
$0
0 Shares
Direct Sells
3
($1.03) M
-4,198 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
11/27/2024
10b5-1
11/27/2024
Sell
-1,531 @ $252.29
($386,261) 12,881 (-10.62%) Direct
11/26/2024
11/27/2024
Sell
-1,469 @ $250.98
($368,686) 14,412 (-9.25%) Direct
06/25/2024
06/26/2024
Sell
-1,198 @ $230.99
($276,731) 14,181 (-7.79%) Direct